Suita, Japan

Yusuke Yamai

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yusuke Yamai. Retrieved from https://idiyas.com/inventor/yusuke-yamai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yusuke Yamai: Innovator in Bicyclic Heterocyclic Compounds

Introduction

Yusuke Yamai is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various pathologies.

Latest Patents

Yamai holds a patent for a bicyclic heterocyclic compound. This invention provides a compound for the treatment or prophylaxis of conditions involving the sympathetic nervous system, specifically targeting diseases such as neuropathic pain, nociceptive pain, dysuria, and multiple sclerosis. The compound is represented by a specific formula, which includes various chemical groups and structures.

Career Highlights

Throughout his career, Yusuke Yamai has worked with prominent companies in the pharmaceutical industry, including Dainippon Sumitomo Pharma Co., Ltd. and Sumitomo Dainippon Pharma Co., Ltd. His work has focused on innovative solutions to complex medical issues.

Collaborations

Yamai has collaborated with esteemed colleagues such as Hitoshi Watanabe and Hironori Kinoshita. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Yusuke Yamai's contributions to the field of pharmaceuticals through his innovative compounds demonstrate his commitment to improving medical treatments. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…